Literature DB >> 16333938

Efficacy and outcomes of clarithromycin treatment for pulmonary MAC disease.

T Fujikane1, S Fujiuchi, Y Yamazaki, M Sato, Y Yamamoto, A Takeda, Y Nishigaki, Y Fujita, T Shimizu.   

Abstract

SETTING: Retrospective review of patients with pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin.
OBJECTIVES: To investigate whether the short-term response to treatment predicts long-term outcomes, and to analyse what explanatory variables are associated with the efficacy and outcome of treatment.
DESIGN: Sputum conversion rates in short- and long-term outcomes were evaluated for 111 patients. Respectively 9 and 10 explanatory variables were analysed for their association with both response and outcomes.
RESULTS: Eighty-four patients (75.7%) showed good short-term response and 94 (82.0%) showed good long-term outcomes. Women and patients with satisfactory nutrition status showed good short-term response. Patients with small lesions and those treated for >12 months after sputum conversion showed good long-term outcomes. Patients who showed good short-term response, in the group with large lesions, showed significantly good long-term outcomes (P = 0.0382).
CONCLUSION: There were differences between prognostic factors reflecting short-term response and long-term outcomes. The short-term response predicts long-term outcomes in certain groups divided by prognostic factor. To establish standard treatment for pulmonary MAC disease, it is important to determine a standardised method of evaluation of treatment taking such factors into consideration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333938

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.

Authors:  Yun Su Sim; Hye Yun Park; Kyeongman Jeon; Gee Young Suh; O Jung Kwon; Won-Jung Koh
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

2.  Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease.

Authors:  Eun Young Kim; Su Young Chi; In Jae Oh; Kyu Sik Kim; Yu Il Kim; Sung Chul Lim; Young Chul Kim; Yong Soo Kwon
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

3.  Epidemiology and clinical features of pulmonary nontuberculous mycobacteriosis in Nagasaki, Japan.

Authors:  Shotaro Ide; Shigeki Nakamura; Yoshihiro Yamamoto; Yoshihisa Kohno; Yuichi Fukuda; Hideki Ikeda; Eisuke Sasaki; Katsunori Yanagihara; Yasuhito Higashiyama; Kohji Hashiguchi; Yoji Futsuki; Yuichi Inoue; Kiyoyasu Fukushima; Naofumi Suyama; Shigeru Kohno
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

4.  The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease.

Authors:  Yutaka Ito; Toyohiro Hirai; Kohei Fujita; Takeshi Kubo; Koichi Maekawa; Satoshi Ichiyama; Kaori Togashi; Michiaki Mishima
Journal:  BMC Infect Dis       Date:  2014-09-29       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.